Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Julie Fox

Showing results (11-20 of 182) with videos related to

Pageof 19
Sort By:
AIDS (London, England)|July 7, 2022
The risks associated with stopping injectable antiretroviral treatment in women who are trying to conceive: a case seriesHarry Coleman, Julie Fox, Daniella Chilton
Pharmacogenomics|June 7, 2006
The clinical implications of antiretroviral pharmacogenomicsJulie Fox, Marta Boffito, Alan Winston
AIDS (London, England)|November 30, 2016
Tenofovir disoproxil fumarate-associated bone loss: does vitamin D-binding protein play a role?Frank A Post, Lisa Hamzah, Julie Fox
Australian Family Physician|May 30, 2003
Sex in the suburbsJulie Fox, D Weerasinghe, Katerina Lagios, et al.
Current Opinion in Infectious Diseases|January 15, 2008
Primary HIV infection: to treat or not to treat?Sarah Fidler, Julie Fox, Kholoud Porter, et al.
Sexually Transmitted Infections|June 9, 2016
Diagnosing acute HIV infection at point of care: a retrospective analysis of the sensitivity and specificity of a fourth-generation point-of-care test for detection of HIV core protein p24Naomi Fitzgerald, Maria Cross, Siobhan O'Shea, et al.
Journal of the International AIDS Society|June 26, 2025
HIV Post Exposure Prophylaxis: prospects, opportunities and challengesJulie Fox, Euphemia L Sibanda, Peter Godfrey-Faussett
Journal of the International AIDS Society|June 26, 2025
Modelling the impact of initiation delay, duration and prior PrEP on the efficacy of post-exposure prophylaxis containing a tenofovir/emtricitabine backboneLanxin Zhang, Simon Collins, Julie Fox, et al.
The Journal of Infectious Diseases|November 9, 2014
How Many HIV infections may be averted by targeting primary infection in men who have sex with men? Quantification of changes in transmission-risk behavior, using an individual-based modelPeter J White, Julie Fox, Jonathan Weber, et al.
AIDS Research and Human Retroviruses|September 22, 2010
Improvement in vitamin D deficiency following antiretroviral regime change: Results from the MONET trialJulie Fox, Barry Peters, Manyu Prakash, et al.
Pageof 19

Showing results (11-20 of 182) with videos related to

Sort By:
Pageof 19
AIDS (London, England)|July 7, 2022
The risks associated with stopping injectable antiretroviral treatment in women who are trying to conceive: a case seriesHarry Coleman, Julie Fox, Daniella Chilton
Pharmacogenomics|June 7, 2006
The clinical implications of antiretroviral pharmacogenomicsJulie Fox, Marta Boffito, Alan Winston
AIDS (London, England)|November 30, 2016
Tenofovir disoproxil fumarate-associated bone loss: does vitamin D-binding protein play a role?Frank A Post, Lisa Hamzah, Julie Fox
Australian Family Physician|May 30, 2003
Sex in the suburbsJulie Fox, D Weerasinghe, Katerina Lagios, et al.
Current Opinion in Infectious Diseases|January 15, 2008
Primary HIV infection: to treat or not to treat?Sarah Fidler, Julie Fox, Kholoud Porter, et al.
Sexually Transmitted Infections|June 9, 2016
Diagnosing acute HIV infection at point of care: a retrospective analysis of the sensitivity and specificity of a fourth-generation point-of-care test for detection of HIV core protein p24Naomi Fitzgerald, Maria Cross, Siobhan O'Shea, et al.
Journal of the International AIDS Society|June 26, 2025
HIV Post Exposure Prophylaxis: prospects, opportunities and challengesJulie Fox, Euphemia L Sibanda, Peter Godfrey-Faussett
Journal of the International AIDS Society|June 26, 2025
Modelling the impact of initiation delay, duration and prior PrEP on the efficacy of post-exposure prophylaxis containing a tenofovir/emtricitabine backboneLanxin Zhang, Simon Collins, Julie Fox, et al.
The Journal of Infectious Diseases|November 9, 2014
How Many HIV infections may be averted by targeting primary infection in men who have sex with men? Quantification of changes in transmission-risk behavior, using an individual-based modelPeter J White, Julie Fox, Jonathan Weber, et al.
AIDS Research and Human Retroviruses|September 22, 2010
Improvement in vitamin D deficiency following antiretroviral regime change: Results from the MONET trialJulie Fox, Barry Peters, Manyu Prakash, et al.
Pageof 19